Press Releases

Aptar’s Nasal Unidose Device Approved by US FDA for First Needle-Free Rescue Treatment for Severe Hypoglycemia

AptarGroup, Inc. , a global leader in dispensing and drug delivery solutions, announced that its Unidose Powder System was recently approved by the U.S. FDA for an intranasal, needle-free rescue treatment drug intended to treat severe hypoglycemia in people...

Clariant Adds Pharmaceutical Desiccant Packet Production Capability in Cuddalore, India

The Clariant Healthcare Packaging business unit is now producing desiccant packets at its plant in Cuddalore, Tamil Nadu, India. The addition expands the range of desiccant products immediately available to customers in the region and increases global capacity. The plant...

MedPharm Expands Relationship With Novan On Formulation Science

MedPharm Ltd, a leader in topical and transdermal drug delivery, has expanded its relationship with biopharmaceutical company Novan Inc. MedPharm has previously supported Novan by testing the company’s unique formulations using its proprietary in vitro models to optimise Novan’s formulations...

Boehringer Ingelheim Expands Idiopathic Pulmonary Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics

Boehringer Ingelheim and Bridge Biotherapeutics Inc. announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge Biotherapeutics’s autotaxin inhibitor BBT-877 for patients with fibrosing interstitial lung diseases, including IPF. BBT-877 is...

Sernova Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data

Sernova Corp, a clinical-stage regenerative medicine company announced that its human Phase I/II clinical trial for type-1 diabetes is advancing with additional patients for device and cell transplantation. Sernova announced on July 3, 2019, a case study describing preliminary data...

CURE Pharmaceutical Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients

CURE Pharmaceutical , an innovative drug delivery and development company announced the allowance of U.S, which covers edible thin films with natural active ingredients located in both a powder coating and the film matrix for a bi-phasic release profile. “With...

Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain

Cryoport and EVERSANA have announced a strategic alliance to further create a fully integrated regenerative medicine supply chain solution. The alliance will be designed to leverage EVERSANA's position as the leading provider of commercial services addressing access, affordability and adherence...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read